Home / Topics / biosecurity divestiture

biosecurity divestiture Podcasts

1 episode about biosecurity divestiture

Ginkgo Bioworks Holdings, Inc. (DNA) Announced Q4 2025 Earnings on February 26, 2026, Reporting "Cell engineering revenue was $26 million in the fourth quarter of 2025" artwork

Ginkgo Bioworks Holdings, Inc. (DNA) Announced Q4 2025 Earnings on February 26, 2026, Reporting "Cell engineering revenue was $26 million in the fourth quarter of 2025"
Ginkgo Bioworks Holdings Inc. (DNA)
• 17:11 •Ep 41 •The Earnings Debate •▶ Play on Apple